ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,573.05
0.38%
Dow Jones
41,350.93
-0.20%
Gold vs US Dollar
2,944.255
0.22%
Brent Oil
70.415
-0.39%
Bitcoin
83,044.47
-0.76%
Pepperstone
Advertisement
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Lexeo Therapeutics Inc (LXEO)

  7. Lexeo Therapeutics Inc (LXEO) News

Lexeo Therapeutics (LXEO)

Lexeo Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:LXEO
DateTimeSourceHeadlineSymbolCompany
21/02/202522:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LXEOLexeo Therapeutics Inc
21/02/202522:09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LXEOLexeo Therapeutics Inc
21/02/202522:09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LXEOLexeo Therapeutics Inc
21/02/202522:08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LXEOLexeo Therapeutics Inc
19/02/202521:25Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:LXEOLexeo Therapeutics Inc
19/02/202521:19Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:LXEOLexeo Therapeutics Inc
19/02/202521:15Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:LXEOLexeo Therapeutics Inc
19/02/202521:06Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:LXEOLexeo Therapeutics Inc
12/02/202514:35Edgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:LXEOLexeo Therapeutics Inc
04/02/202520:45Edgar (US Regulatory)Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:LXEOLexeo Therapeutics Inc
22/01/202521:55Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LXEOLexeo Therapeutics Inc
13/01/202512:35Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LXEOLexeo Therapeutics Inc
10/01/202521:55Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LXEOLexeo Therapeutics Inc
10/01/202521:55Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LXEOLexeo Therapeutics Inc
10/01/202521:55Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LXEOLexeo Therapeutics Inc
10/01/202521:55Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LXEOLexeo Therapeutics Inc
10/01/202521:55Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LXEOLexeo Therapeutics Inc
07/01/202512:30GlobeNewswire Inc.Lexeo Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceNASDAQ:LXEOLexeo Therapeutics Inc
27/12/202419:59Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:LXEOLexeo Therapeutics Inc
20/12/202405:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:LXEOLexeo Therapeutics Inc
19/12/202412:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LXEOLexeo Therapeutics Inc
19/12/202412:00GlobeNewswire Inc.Lexeo Therapeutics Appoints Kyle Rasbach as Chief Financial OfficerNASDAQ:LXEOLexeo Therapeutics Inc
13/12/202413:19Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:LXEOLexeo Therapeutics Inc
12/12/202422:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LXEOLexeo Therapeutics Inc
10/12/202422:18Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:LXEOLexeo Therapeutics Inc
04/12/202405:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:LXEOLexeo Therapeutics Inc
02/12/202422:04Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:LXEOLexeo Therapeutics Inc
13/11/202422:33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LXEOLexeo Therapeutics Inc
13/11/202412:35Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:LXEOLexeo Therapeutics Inc
13/11/202412:33Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:LXEOLexeo Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:LXEO

Your Recent History

TG
TOC
ThomsonReuters
TG
T5R
Tecnicas Reunidas
TG
MAQ
Marriott International I...
TSXV
DE
Decisive Dividend
TG
AXV
Axis Capital
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2025 ADVFN PLC - All Rights Reserved

    Go Ad-Free

    Subscribe to Ad free and enjoy an ad-free experience

    No Ads

    Try Now

    Keep the Ads